P. Martínez Martín

Social robots in advanced dementia

Meritxell Valentí Soler, L. Agüera-Ortiz, J. Olazarán Rodríguez, 2015, Front. Aging Neurosci..

Falls and long-term survival among older adults residing in care homes

P. Martínez Martín, R. Pastor-Barriuso, J. Damián, 2020, PloS one.

A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice

J. Kulisevsky, M. Rodriguez-Oroz, F. Valldeoriola, 2020, Brain sciences.

Erratum: Pagonabarraga, J.; et al. A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice. Brain Sci. 2020, 10, 176

J. Kulisevsky, M. Rodriguez-Oroz, F. Valldeoriola, 2020, Brain sciences.

Controlled release levodopa in Parkinson's disease: influence of selection criteria and conversion recommendations in the clinical outcome of 450 patients. STAR Study Group.

P. Martínez Martín, F. Grandas, G. Linazasoro, 1999, Clinical neuropharmacology.

Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease

J. Kulisevsky, P. Martínez Martín, C. Rodríguez-Blázquez, 2010, Movement disorders : official journal of the Movement Disorder Society.

[Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease].

P. Martínez Martín, B. Frades, E. Cubo, 2009, Neurologia.

Non motor symptoms in progressive supranuclear palsy: prevalence and severity

K. Chaudhuri, P. Martínez Martín, L. Vacca, 2017, npj Parkinson's Disease.

Burden of disease related to Parkinson's disease in Spain in the year 2000

P. Martínez Martín, E. Álvarez, E. Cubo, 2005, Movement disorders : official journal of the Movement Disorder Society.

ICF-Based Disability Survey in a Rural Population of Adults and Older Adults Living in Cinco Villas, Northeastern Spain: Design, Methods and Population Characteristics

R. Magallón, A. Cieza, P. Martínez Martín, 2010, Neuroepidemiology.

What contributes to driving ability in Parkinson's disease

Alberto Bergareche, Victor Campos, P. Martínez Martín, 2010, Disability and rehabilitation.